Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA

Patricia Valda Toro, Bracha Erlanger, Julia Beaver, Rory L. Cochran, Dustin A. VanDenBerg, Elizabeth Yakim, Karen Cravero, David Chu, Daniel J. Zabransky, Hong Yuen Wong, Sarah Croessmann, Heather Parsons, Paula Hurley, Josh Lauring, Ben Ho Park

Research output: Contribution to journalArticle

Abstract

Objectives: Circulating plasma DNA is being increasingly used for biomedical and clinical research as a substrate for genetic testing. However, cell lysis can occur hours after venipuncture when using standard tubes for blood collection, leading to an increase in contaminating cellular DNA that may hinder analysis of circulating plasma DNA. Cell stabilization agents can prevent cellular lysis for several days, reducing the need for immediate plasma preparation after venipuncture, thereby facilitating the ease of blood collection and sample preparation for clinical research. However, the majority of cell stabilizing reagents have not been formally tested for their ability to preserve circulating plasma tumor DNA. Design & methods: In this study, we compared the properties of two cell stabilizing reagents, the cell-free DNA BCT tube and the PAXgene tube, by collecting blood samples from metastatic breast cancer patients and measuring genome equivalents of plasma DNA by droplet digital PCR. We compared wild type PIK3CA genome equivalents and also assayed for two PIK3CA hotspot mutations, E545K and H1047R. Results: Our results demonstrate that blood stored for 7. days in BCT tubes did not show evidence of cell lysis, whereas PAXgene tubes showed an order of magnitude increase in genome equivalents, indicative of considerable cellular lysis. Conclusions: We conclude that BCT tubes can prevent lysis and cellular release of genomic DNA of blood samples from cancer patients when stored at room temperature, and could therefore be of benefit for blood specimen collections in clinical trials.

Original languageEnglish (US)
Pages (from-to)993-998
Number of pages6
JournalClinical Biochemistry
Volume48
Issue number15
DOIs
StatePublished - Oct 1 2015

Fingerprint

Tumors
Blood Cells
Blood
Plasmas
DNA
Neoplasms
Phlebotomy
Genes
Genome
Blood Specimen Collection
Genetic Testing
Biomedical Research
Stabilization
Clinical Trials
Breast Neoplasms
Polymerase Chain Reaction
Mutation
Temperature
Testing
Substrates

Keywords

  • Cell stabilizing tube
  • Circulating tumor DNA
  • Droplet digital PCR
  • Plasma tumor DNA

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Toro, P. V., Erlanger, B., Beaver, J., Cochran, R. L., VanDenBerg, D. A., Yakim, E., ... Park, B. H. (2015). Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. Clinical Biochemistry, 48(15), 993-998. https://doi.org/10.1016/j.clinbiochem.2015.07.097

Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. / Toro, Patricia Valda; Erlanger, Bracha; Beaver, Julia; Cochran, Rory L.; VanDenBerg, Dustin A.; Yakim, Elizabeth; Cravero, Karen; Chu, David; Zabransky, Daniel J.; Wong, Hong Yuen; Croessmann, Sarah; Parsons, Heather; Hurley, Paula; Lauring, Josh; Park, Ben Ho.

In: Clinical Biochemistry, Vol. 48, No. 15, 01.10.2015, p. 993-998.

Research output: Contribution to journalArticle

Toro, PV, Erlanger, B, Beaver, J, Cochran, RL, VanDenBerg, DA, Yakim, E, Cravero, K, Chu, D, Zabransky, DJ, Wong, HY, Croessmann, S, Parsons, H, Hurley, P, Lauring, J & Park, BH 2015, 'Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA', Clinical Biochemistry, vol. 48, no. 15, pp. 993-998. https://doi.org/10.1016/j.clinbiochem.2015.07.097
Toro, Patricia Valda ; Erlanger, Bracha ; Beaver, Julia ; Cochran, Rory L. ; VanDenBerg, Dustin A. ; Yakim, Elizabeth ; Cravero, Karen ; Chu, David ; Zabransky, Daniel J. ; Wong, Hong Yuen ; Croessmann, Sarah ; Parsons, Heather ; Hurley, Paula ; Lauring, Josh ; Park, Ben Ho. / Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. In: Clinical Biochemistry. 2015 ; Vol. 48, No. 15. pp. 993-998.
@article{3ddf422888024df991c450b4fde2ddc8,
title = "Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA",
abstract = "Objectives: Circulating plasma DNA is being increasingly used for biomedical and clinical research as a substrate for genetic testing. However, cell lysis can occur hours after venipuncture when using standard tubes for blood collection, leading to an increase in contaminating cellular DNA that may hinder analysis of circulating plasma DNA. Cell stabilization agents can prevent cellular lysis for several days, reducing the need for immediate plasma preparation after venipuncture, thereby facilitating the ease of blood collection and sample preparation for clinical research. However, the majority of cell stabilizing reagents have not been formally tested for their ability to preserve circulating plasma tumor DNA. Design & methods: In this study, we compared the properties of two cell stabilizing reagents, the cell-free DNA BCT tube and the PAXgene tube, by collecting blood samples from metastatic breast cancer patients and measuring genome equivalents of plasma DNA by droplet digital PCR. We compared wild type PIK3CA genome equivalents and also assayed for two PIK3CA hotspot mutations, E545K and H1047R. Results: Our results demonstrate that blood stored for 7. days in BCT tubes did not show evidence of cell lysis, whereas PAXgene tubes showed an order of magnitude increase in genome equivalents, indicative of considerable cellular lysis. Conclusions: We conclude that BCT tubes can prevent lysis and cellular release of genomic DNA of blood samples from cancer patients when stored at room temperature, and could therefore be of benefit for blood specimen collections in clinical trials.",
keywords = "Cell stabilizing tube, Circulating tumor DNA, Droplet digital PCR, Plasma tumor DNA",
author = "Toro, {Patricia Valda} and Bracha Erlanger and Julia Beaver and Cochran, {Rory L.} and VanDenBerg, {Dustin A.} and Elizabeth Yakim and Karen Cravero and David Chu and Zabransky, {Daniel J.} and Wong, {Hong Yuen} and Sarah Croessmann and Heather Parsons and Paula Hurley and Josh Lauring and Park, {Ben Ho}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.clinbiochem.2015.07.097",
language = "English (US)",
volume = "48",
pages = "993--998",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "15",

}

TY - JOUR

T1 - Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA

AU - Toro, Patricia Valda

AU - Erlanger, Bracha

AU - Beaver, Julia

AU - Cochran, Rory L.

AU - VanDenBerg, Dustin A.

AU - Yakim, Elizabeth

AU - Cravero, Karen

AU - Chu, David

AU - Zabransky, Daniel J.

AU - Wong, Hong Yuen

AU - Croessmann, Sarah

AU - Parsons, Heather

AU - Hurley, Paula

AU - Lauring, Josh

AU - Park, Ben Ho

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objectives: Circulating plasma DNA is being increasingly used for biomedical and clinical research as a substrate for genetic testing. However, cell lysis can occur hours after venipuncture when using standard tubes for blood collection, leading to an increase in contaminating cellular DNA that may hinder analysis of circulating plasma DNA. Cell stabilization agents can prevent cellular lysis for several days, reducing the need for immediate plasma preparation after venipuncture, thereby facilitating the ease of blood collection and sample preparation for clinical research. However, the majority of cell stabilizing reagents have not been formally tested for their ability to preserve circulating plasma tumor DNA. Design & methods: In this study, we compared the properties of two cell stabilizing reagents, the cell-free DNA BCT tube and the PAXgene tube, by collecting blood samples from metastatic breast cancer patients and measuring genome equivalents of plasma DNA by droplet digital PCR. We compared wild type PIK3CA genome equivalents and also assayed for two PIK3CA hotspot mutations, E545K and H1047R. Results: Our results demonstrate that blood stored for 7. days in BCT tubes did not show evidence of cell lysis, whereas PAXgene tubes showed an order of magnitude increase in genome equivalents, indicative of considerable cellular lysis. Conclusions: We conclude that BCT tubes can prevent lysis and cellular release of genomic DNA of blood samples from cancer patients when stored at room temperature, and could therefore be of benefit for blood specimen collections in clinical trials.

AB - Objectives: Circulating plasma DNA is being increasingly used for biomedical and clinical research as a substrate for genetic testing. However, cell lysis can occur hours after venipuncture when using standard tubes for blood collection, leading to an increase in contaminating cellular DNA that may hinder analysis of circulating plasma DNA. Cell stabilization agents can prevent cellular lysis for several days, reducing the need for immediate plasma preparation after venipuncture, thereby facilitating the ease of blood collection and sample preparation for clinical research. However, the majority of cell stabilizing reagents have not been formally tested for their ability to preserve circulating plasma tumor DNA. Design & methods: In this study, we compared the properties of two cell stabilizing reagents, the cell-free DNA BCT tube and the PAXgene tube, by collecting blood samples from metastatic breast cancer patients and measuring genome equivalents of plasma DNA by droplet digital PCR. We compared wild type PIK3CA genome equivalents and also assayed for two PIK3CA hotspot mutations, E545K and H1047R. Results: Our results demonstrate that blood stored for 7. days in BCT tubes did not show evidence of cell lysis, whereas PAXgene tubes showed an order of magnitude increase in genome equivalents, indicative of considerable cellular lysis. Conclusions: We conclude that BCT tubes can prevent lysis and cellular release of genomic DNA of blood samples from cancer patients when stored at room temperature, and could therefore be of benefit for blood specimen collections in clinical trials.

KW - Cell stabilizing tube

KW - Circulating tumor DNA

KW - Droplet digital PCR

KW - Plasma tumor DNA

UR - http://www.scopus.com/inward/record.url?scp=84943588034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943588034&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2015.07.097

DO - 10.1016/j.clinbiochem.2015.07.097

M3 - Article

C2 - 26234639

AN - SCOPUS:84943588034

VL - 48

SP - 993

EP - 998

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 15

ER -